0001104659-19-047536.txt : 20190827 0001104659-19-047536.hdr.sgml : 20190827 20190827172704 ACCESSION NUMBER: 0001104659-19-047536 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190823 FILED AS OF DATE: 20190827 DATE AS OF CHANGE: 20190827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khattar Jack A. CENTRAL INDEX KEY: 0001539937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 191058549 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 1550 EAST GUDE DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 a4.xml 4 X0306 4 2019-08-23 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001539937 Khattar Jack A. C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE STREET ROCKVILLE MD 20850 1 1 0 0 President, CEO Common Stock 2019-08-23 4 P 0 7200 26.3864 A 465141 D Common Stock 1081450 I By the KBT Trust Common Stock 2900 I By son The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.5100, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Includes an aggregate of 376 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. /s/ Gregory S. Patrick, as attorney-in-fact 2019-08-27